MedTech Daily: 15 New Press Releases for Friday, June 13, 2025


In This Issue:

Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to!

Here are the press categories for today:

Category:

  • Clinical & Regulatory: 1
  • Products & Patents: 1
  • General Announcements: 2
  • Legal: 11

Clinical & Regulatory

InspireMD, Inc. (NSPR | DoD: +2.04% | YTD: -6.02% | SmallCap: 78M)

  • Profile: Developer of the CGuard‚Ñ¢ Prime carotid stent system for the prevention of stroke
  • CE Mark: InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke (Full Text)

Products & Patents

Thermo Fisher Scientific Inc. (TMO | DoD: +0.04% | YTD: -20.46% | LargeCap: 148.8B)

  • Profile: Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services
  • Collaboration: Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms (Full Text)

General Announcements

Catheter Precision, Inc. (VTAK | DoD: -28.35% | YTD: -4.25% | SmallCap: 2M)

  • Profile: A US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market
  • Announcement: Catheter Precision, Inc. Comments on Recent Market Activity (Full Text)

Nyxoah SA (NYXH | DoD: -2.45% | YTD: -16.37% | SmallCap: 291M)

  • Profile: A medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA)
  • Event: Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025 (Full Text)

Legal

GeneDx Holdings Corp. (WGS | DoD: -5.62% | YTD: -16.65% | MidCap: 2.1B)

  • Profile: Maker of industry-leading exome and genome tests that translate complex genomic data into clinical answers
  • Legal: Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGS (Full Text)

GeneDx Holdings Corp. (WGS | DoD: -5.62% | YTD: -16.65% | MidCap: 2.1B)

  • Profile: Maker of industry-leading exome and genome tests that translate complex genomic data into clinical answers
  • Legal: WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm (Full Text)

Globus Medical, Inc. (GMED | DoD: -0.99% | YTD: -26.43% | MidCap: 8.1B)

  • Profile: A leading musculoskeletal technology company
  • Legal: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED (Full Text)

Integra LifeSciences Holdings Corporation (IART | DoD: -1.09% | YTD: -44.87% | SmallCap: 954M)

  • Profile: A leading global medical technology company
  • Legal: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART (Full Text)

Neogen Corporation (NEOG | DoD: -1.49% | YTD: -52.93% | MidCap: 1.2B)

  • Profile: An innovative leader in food safety solutions
  • Legal: Neogen Corporation (NEOG) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights (Full Text)

NeuroPace, Inc. (NPCE | DoD: -5.07% | YTD: -3.02% | SmallCap: 428M)

  • Profile: Founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders
  • Legal: Potential Securities Fraud: Levi & Korsinsky Investigates NeuroPace, Inc. (NPCE) (Full Text)

West Pharmaceutical Services, Inc. (WST | DoD: +0.40% | YTD: -31.40% | MidCap: 15.1B)

  • Profile: Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products
  • Legal: WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! (Full Text)

West Pharmaceutical Services, Inc. (WST | DoD: +0.40% | YTD: -31.40% | MidCap: 15.1B)

  • Profile: Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products
  • Legal: Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST (Full Text)

West Pharmaceutical Services, Inc. (WST | DoD: +0.40% | YTD: -31.40% | MidCap: 15.1B)

  • Profile: Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products
  • Legal: WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit (Full Text)

West Pharmaceutical Services, Inc. (WST | DoD: +0.40% | YTD: -31.40% | MidCap: 15.1B)

  • Profile: Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products
  • Legal: July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky (Full Text)

West Pharmaceutical Services, Inc. (WST | DoD: +0.40% | YTD: -31.40% | MidCap: 15.1B)

  • Profile: Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products
  • Legal: West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline (Full Text)

The MedTech Daily Newsletter

We track the 250+ publicly traded MedTech companies so you don't have to!

Read more from The MedTech Daily Newsletter

In This Issue: Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to! Here are the press categories for today: Category: Finance: 4 Clinical & Regulatory: 7 Products & Patents: 7 General Announcements: 3 Leadership Updates: 2 Finance IDEXX Laboratories, Inc. (IDXX | DoD: +1.12% | YTD: +29.75% | LargeCap: 42.2B) Profile: A global leader in pet healthcare innovation Reporting: IDEXX Laboratories to Release 2025 Second Quarter...

In This Issue: Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to! Here are the press categories for today: Category: Finance: 2 Clinical & Regulatory: 4 Products & Patents: 7 General Announcements: 3 Leadership Updates: 2 Mergers & Acquisitions: 1 Finance PAVmed Inc. (PAVM | DoD: +5.71% | YTD: -4.20% | SmallCap: 11M) Profile: A commercial-stage, cancer prevention medical diagnostics company Financing: PAVmed Subsidiary Veris...

In This Issue: Every morning we scan the headlines of the 250+ publicly traded medical technology companies so that you don't have to! Here are the press categories for today: Category: Finance: 1 Clinical & Regulatory: 5 Products & Patents: 3 General Announcements: 2 Leadership Updates: 2 Mergers & Acquisitions: 2 Finance Innovative Eyewear, Inc. (LUCY | DoD: +54.82% | YTD: -34.51% | SmallCap: 10M) Profile: The developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer ® and...